February is American Heart Month, an annual campaign that aims to raise awareness about heart health and cardiovascular ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

February is American Heart Month, an annual campaign that aims to raise awareness about heart health and cardiovascular diseases.

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for ...

Heart disease claims more lives in America than any other medical problem every year, therefore keeping your heart and ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

Guthrie officials said that cardiovascular diseases are the leading killer in the United States, but there are steps that ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

While common risk factors like high blood pressure, high cholesterol, obesity and smoking are well-known, there are other ...

Once you have had a heart attack or have been diagnosed with a heart problem - there is always confusion about whether you ...

For days, she dealt with the nagging pain. One day, she and her daughter went to the mall, and Caprario decided to run up and down the stairs to try and relieve the discomfort. On other days, she ...